LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breas...( TORRANCE Combined hormone therapy a...),Health
Navigation Links
LA BioMed study finds hormone therapy increases frequency of abnormal mammograms, breast biopsies
Date:2/25/2008
TORRANCE Combined hormone therapy appears to increase the risk that women will have abnormal mammograms and breast biopsies, and it may decrease the effectiveness of both methods for detecting breast cancer, according to a report in the Feb. 25 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.
Rowan T. Chlebowski, M.D., Ph.D., a lead investigator at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed), was the lead author of the report. He and his colleagues studied 16,608 post-menopausal women who participated in the Womens Health Initiative (WHI) clinical trial, a 15-year study that began in 1993.
The research team examined the effect of combined hormone therapy on breast cancer detection over five years and found it resulted in more than one in 10 women having otherwise avoidable mammogram abnormalities and one in 25 women having breast biopsies. Combined hormone therapy also compromised the diagnostic performance of mammograms and breast biopsies.
These findings represent a concern for post-menopausal women who are considering hormone therapy, said Dr. Chlebowski. They should take the results of this study into consideration and consult with their physicians before undergoing even short-term hormone therapy.
The study examined the use of conjugated equine estrogens plus medroxyprogesterone acetate for approximately five years. A total of 8,506 women were randomly assigned to receive a combination of estrogen (0.625 milligrams of conjugated equine estrogens per day) plus progesterone (2.5 milligrams of medroxyprogesterone acetate per day), while 8,102 took a placebo. Each woman received a mammogram and breast examination yearly, with biopsies performed based on physicians clinical judgment.
During the 5.6 years of the study, 199 women in the combined hormone group and 150 women in the placebo group developed breast cancer. Mammograms with abnormal result
'/>"/>
| Contact: Laura Mecoy Lmecoy@issuesmanagement.com 310-546-5860 Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) Source:Eurekalert |
Related medicine news :
1. BioMed Realty Trust Joint Venture Enters Into New $245 Million Construction Loan and Extends Term of Existing Loan Facility
2. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
3. 7th Annual Wiley Prize in Biomedical Sciences Awarded to Dr. Richard P. Lifton
4. Lung Cancer Alliance Urges Inclusion of $5 Billion for Biomedical Research in Economic Stimulus Package
5. BioMed Central bolsters radiology image collection
6. New nanotube findings by Stanford researchers give boost to potential biomedical applications
7. American Red Cross Announces New Leader for Biomedical Services
8. XCPT(TM) Patient Engagement and Communication Software Signs Representation Agreement with Lifecore Biomedical, Inc. (Nasdaq: LCBM)
9. BioMed Realty Trust Declares Fourth Quarter 2007 Common Stock and Preferred Stock Dividends
10. LA BioMed researchers find few emergency rooms fully equipped for pediatric patients
11. LA BioMed research finds simpler way to assess breast cancer risk
Post Your Comments:
(Date:12/1/2009)... , , NEWPORT BEACH, Calif., Dec. 1 /PRN...lling code that insurers will reimburse them for t...n monitor for ,going under, for surgery. ,, Ane...nt brain monitoring is to avoid postop dementia fr...hesiologists have not heard the ,avoid over-medica...
(Date:12/1/2009)... , , SEATTLE, Dec. 1 /PRNewswire-F... and MTA: CTIC) management,s presentation at the 2... Tuesday, December 1 at 11:00 a.m. Eastern Time wi... ,, The presentation will take place in Holmes...available for replay after the presentation. , ,...
(Date:12/1/2009)... , CHICAGO A study presented today at the annual...ica (RSNA) revealed that MRI is a highly accurate ...ly life-threatening and increasingly common condit...ust before and after giving birth. , "Due to th...s that leave scarring on the uterine wall, coupled...
(Date:12/1/2009)... , CHICAGO Results of a randomized, controlled c...g of the Radiological Society of North America (RS...g or blockage in arteries that supply blood to the...icant but silent coronary artery disease. , Per... a combination of fat, cholesterol and other subst...
(Date:12/1/2009)... , The first ever published study of aviation-rel...re than 1,013 patients are admitted to U.S. hospit...hat 753 aviation-deaths occur each year. The study...Bloomberg School of Public Health,s Center for Inj...lso reports that the largest categories of patient...
Breaking Medicine News(10 mins):Health News:5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed 2Health News:MRI helps detect life-threatening pregnancy complication 2Health News:Severe asymptomatic heart disease may accompany narrowing in leg arteries 2Health News:More than 1,000 patients in US admitted annually for aviation-related injuries 2[0] 5 Shocking Reasons Your Brain Isn't Worth Twenty Bucks Exposed[0] Cell Therapeutics, Inc. (CTI) Piper Jaffray Presentation to be Webcast[0] MRI helps detect life-threatening pregnancy complication[0] Severe asymptomatic heart disease may accompany narrowing in leg arteries[0] More than 1,000 patients in US admitted annually for aviation-related injuries
...sorder, arterial trouble , FRIDAY, Oct. 12 (Health...sitive airway pressure (CPAP) to treat people with...y indications of atherosclerosis -- hardening of t...therosclerosis, Brazilian researchers say. , The s...
...eaction times , , SATURDAY, Oct. 13 (Healt...in medications such as morphine does not impair a ... , A team at Rush University Medical Center in Chi...out 12 minutes in a driving simulator that measure...
...vernor Schwarzenegger signed into law a package of...e and extend benefits to children and youth in,fos...important bill in this,package of legislation will...focus on developing and,strengthening life-long pe...
...Radiology Holdings, Inc. (Nasdaq: NHWK ), a leadi...ups across the United States, today announced that...ber 31, 2007 at 8:30 a.m.,(ET) with management to ... at 8:30 a.m. (ET). A live web cast of the confere...
...ealthcare Research and Quality, part of the U.S. D...today the award of $41.6 million over the next 4,y... centers as part of its,Centers for Education and ...tics,Program allows AHRQ to build a strong evidenc...
...e, Will Challenge,Corporate-Backed Proponents of "... University,professor Dale Nance, co-author of the...al Injustice, will be one of the featured speakers... Mr. Nance,s report, written with fellow professor...
Other Medicine News:Health News:Sleep Apnea Treatment Helps Stave Off Heart Disease 2Health News:Morphine Painkillers Won't Impair Driving 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 2Health News:California Alliance Applauds Governor's Support of Group Home Reform for Foster Youth 3Health News:NightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference Call 2Health News:AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies 2Health News:AHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies 3Health News:'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel 2Sleep Apnea Treatment Helps Stave Off Heart DiseaseMorphine Painkillers Won't Impair DrivingCalifornia Alliance Applauds Governor's Support of Group Home Reform for Foster YouthNightHawk Radiology Holdings, Inc. Announces Date for Third Quarter Earnings Conference CallAHRQ Expands Therapeutics Education and Research Centers and Adds New Topics: Health IT, Economics, Formularies'Health Courts' Critic to be Featured Speaker at Wyoming Patient Safety Panel
(Date:12/1/2009)..., , NEW YORK, Dec. 1 /PRNewswi...ssure, changing market dynamics for an industry ex...g healthcare reforms are likely to drive up the e...e sciences industry, according to a report releas...a 2020: Taxing times ahead - Which path will you t...
(Date:11/30/2009)..., , HUNTERSVILLE, N.C., Nov. 30 /PRNewswir...der in built-in antimicrobial product protection, ...ca partnership with Dal-Tile Corp., the largest U....d natural stone. Dal-Tile Corp is launching two n...TM) featuring Microban(®) patent pending silv...
(Date:11/30/2009)..., , CHICAGO, Nov. 30 Breast...ibutes to the detection of malignant or high-risk ... mammographic findings, according to results of a ...eting of the Radiological Society of North America...as conducted as an adjunct diagnostic imaging moda...
Breaking Medicine Technology:Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 2Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 3Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 4Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers 5Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology 2BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings 2Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 1Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 2Spherix Incorporated Announces Annual Shareholders Meeting Date 14241 3Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 1Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 2Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 3Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 4Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 5Abbotts XIENCE V 28R 29 Superior to TAXUS 28R 29 in Key Safety and Efficacy Measures in SPIRIT IV Trial 5040 6Predicting Postpartum Depression May Be Possible 58178 1Predicting Postpartum Depression May Be Possible 58178 2[0] Pharmaceutical and Life Sciences Companies Face Rising Tax Rates, Says PricewaterhouseCoopers[0] Dal-Tile Corp. Launches Two New Lines of Ceramic Tile with Microban(R) Silver Antimicrobial Technology[0] BSGI Makes Significant Impact on Detection of Breast Cancer in Patients with Negative Mammographic Findings
...ept of Other Product - Company,s Bioabsorbable Ste...ONG KONG, Oct. 6 Data from multiple clinical tria...ich,s Genous Bio-engineered R,stent, will be prese...,Therapeutics symposium, TCT 2008, in Washington, ...emic Medical Center in,Amsterdam will provide a Ge...
...land, Oct. 3 deCODE genetics,(Nasdaq: DCGN ) tod...drug,(IND) application for DG071, the company,s no...4 (PDE4), with the US Food and Drug Administration...nd potentially safer means,of targeting PDE4 to co...,with Alzheimer,s disease and other disorders in w...
Other Medicine Technology:Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 2Data From Multiple Clinical Trials of OrbusNeich's Genous(TM) Bio-engineered R stent(TM) to be Presented at TCT 2008 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 2deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 3deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 4deCODE Files IND for DG071, a Novel PDE4 Modulator Being Developed for Alzheimer's and Other Cognitive Disorders 5| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |